Metabonomic evaluation of idiosyncrasy-like liver injury in rats cotreated with ranitidine and lipopolysaccharide.

Idiosyncratic liver injury occurs in a small fraction of people on certain drug regimens. The cause of idiosyncratic hepatotoxicity is not known; however, it has been proposed that environmental factors such as concurrent inflammation initiated by bacterial lipopolysaccharide (LPS) increase an individual's susceptibility to drug toxicity. Ranitidine (RAN), a histamine-2 receptor antagonist, causes idiosyncratic liver injury in humans. In a previous report, idiosyncrasy-like liver toxicity was created in rats by cotreating them with LPS and RAN. In the present study, the ability of metabonomic techniques to distinguish animals cotreated with LPS and RAN from those treated with each agent individually was investigated. Rats were treated with LPS or its vehicle and with RAN or its vehicle, and urine was collected for nuclear magnetic resonance (NMR)- and mass spectroscopy-based metabonomic analyses. Blood and liver samples were also collected to compare metabonomic results with clinical chemistry and histopathology. NMR metabonomic analysis indicated changes in the pattern of metabolites consistent with liver damage that occurred only in the LPS/RAN cotreated group. Principal component analysis of urine spectra by either NMR or mass spectroscopy produced a clear separation of the rats treated with LPS/RAN from the other three groups. Clinical chemistry (serum alanine aminotransferase and aspartate aminotransferase activities) and histopathology corroborated these results. These findings support the potential use of a noninvasive metabonomic approach to identify drug candidates with potential to cause idiosyncratic liver toxicity with inflammagen coexposure.

[1]  D. Kell,et al.  RAPID COMMUNICATIONS IN MASS SPECTROMETRY Rapid Commun. Mass Spectrom. 2002; 16: 1276±1286 , 2022 .

[2]  J. Lindon,et al.  An hypothesis for a mechanism underlying hepatotoxin-induced hypercreatinuria , 2003, Archives of Toxicology.

[3]  M. Reily,et al.  Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  Ian D Wilson,et al.  HPLC-MS-based methods for the study of metabonomics. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  Elaine Holmes,et al.  Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis , 2004, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[6]  V. Beral.  ORAL-CONTRACEPTIVES AND HEALTH , 1974 .

[7]  E Holmes,et al.  Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. , 1998, Chemical research in toxicology.

[8]  I. Jolliffe.  Principal Component Analysis , 2002 .

[9]  J. Luyendyk,et al.  Inflammation and Drug Idiosyncrasy—Is There a Connection? , 2003, Journal of Pharmacology and Experimental Therapeutics.

[10]  D. Couteur,et al.  Nephrotoxicity and Hepatotoxicity of Histamine H2 Receptor Antagonists , 2001, Drug safety.

[11]  J. Luyendyk,et al.  Ranitidine Treatment during a Modest Inflammatory Response Precipitates Idiosyncrasy-Like Liver Injury in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[12]  J. Luyendyk,et al.  Bacterial lipopolysaccharide exposure alters aflatoxin B(1) hepatotoxicity: benchmark dose analysis for markers of liver injury. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  ScienceDirect,et al.  Toxicology and Applied Pharmacology , 1959, Nature.

[14]  D. Kell,et al.  High-throughput classification of yeast mutants for functional genomics using metabolic footprinting , 2003, Nature Biotechnology.

[15]  X Yu,et al.  J.Chromatogr., B: Anal. Technol. Biomed. Life Sci. , 2004 .

[16]  Iain Beattie,et al.  Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. , 2004, Rapid communications in mass spectrometry : RCM.

[17]  M. Abdel‐Rahman,et al.  ENDOTOXIN POTENTIATES THE HEPATOTOXICITY OF COCAINE IN MALE MICE , 2002, Journal of toxicology and environmental health. Part A.

[18]  E Holmes,et al.  Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. , 2001, Chemical research in toxicology.

[19]  Elaine Holmes,et al.  NMR-based metabonomic studies on the biochemical effects of commonly used drug carrier vehicles in the rat. , 2002, Chemical research in toxicology.

[20]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[21]  A. J. Gandolfi,et al.  The Involvement of Endotoxin in Halothane‐associated Liver Injury , 1984, Anesthesiology.

[22]  S. Bursian,et al.  Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy? , 2002, The Journal of pharmacology and experimental therapeutics.

[23]  D B Kell,et al.  Discrimination of aerobic endospore-forming bacteria via electrospray-lonization mass spectrometry of whole cell suspensions. , 2001, Analytical chemistry.

[24]  B. Charpentier,et al.  RANITIDINE HEPATOTOXICITY IN RENAL TRANSPLANT PATIENT , 1985, The Lancet.

[25]  D. R. Causton,et al.  A Biologist's Advanced Mathematics , 1977 .

[26]  Robert S Plumb,et al.  Metabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. , 2002, Rapid communications in mass spectrometry : RCM.

[27]  P. Ganey,et al.  Synergistic hepatotoxicity from coexposure to bacterial endotoxin and the pyrrolizidine alkaloid monocrotaline. , 2000, Toxicology and applied pharmacology.

[28]  T. Ebbels,et al.  Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles. , 2004, Chemical research in toxicology.

[29]  D. Kell,et al.  Flow-injection electrospray ionization mass spectrometry of crude cell extracts for high-throughput bacterial identification , 2002, Journal of the American Society for Mass Spectrometry.

[30]  R. Sneed,et al.  Bacterial endotoxin enhances the hepatotoxicity of allyl alcohol. , 1997, Toxicology and applied pharmacology.

[31]  Henrik Antti,et al.  Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. , 2003, Toxicology and applied pharmacology.

[32]  Bryan F. J. Manly,et al.  Multivariate Statistical Methods : A Primer , 1986 .

[33]  Royston Goodacre,et al.  Application of high-throughput Fourier-transform infrared spectroscopy in toxicology studies: contribution to a study on the development of an animal model for idiosyncratic toxicity. , 2004, Toxicology letters.

[34]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.